By Vvon Engineering Team | Published | Updated
Generator and product-specific checks, radiochemical-purity methods and documented release decisions for a nuclear-medicine radiopharmacy.
Nuclear medicine RFQ checklist (TXT)
Unexpected biodistribution can have radiopharmaceutical, clinical or acquisition causes. Preparation and QC records help the clinical team investigate it. A failed labelling process is one possibility, not a diagnosis that can be made from a single organ pattern.
Radiopharmaceutical QC must use the method, timing and acceptance criteria for the specific product. It includes more than a universal strip test and cannot be reduced to a fixed fifteen-minute task for every preparation.
Many technetium cold kits contain a ligand and reducing agent, but formulations and preparation steps differ. Chemical, radionuclidic, physical, microbiological and handling failures are distinct quality issues. Follow the current product instructions and approved radiopharmacy procedure.
Use the exact product instructions for eluate characteristics, activity, volume, handling, incubation, mixing, storage and in-use expiry. A blanket instruction to swirl rather than shake or never use a venting arrangement is not correct for every kit. Staff should use only the validated product-specific method.
Check generator eluate quality according to the current generator instructions, applicable requirements and approved procedure. Molybdenum breakthrough and aluminium testing have different methods and schedules; do not assume that testing only the first elution satisfies every requirement.
Molybdenum-99 breakthrough is assessed with a validated assay arrangement and the generator's stated limit, accounting for the relative decay through the intended administration time. A shielded canister attenuates technetium contribution but does not make an arbitrary activity-meter reading a pure molybdenum measurement. Use the appropriate correction and calibration method.
Aluminium ion. Alumina from the column can break through as aluminium ion, and it does two things: it interferes with labelling, and in a sulphur colloid preparation it causes flocculation which shows as lung uptake on a liver study. The test is a colorimetric spot comparison against a standard supplied with the generator, done on indicator paper in under a minute. The pass limit is on the insert.
Add a visual check to both. The eluate should be clear and colourless. Anything cloudy, coloured or containing particles stops the morning, whatever the tests say.
Radiochemical purity may be assessed by a validated chromatography method or another product-specific method. The stationary phase, solvent, migration pattern, counting method and acceptance limit must match the preparation. A generic two-strip test cannot be applied to all technetium products.
Some products need more than one chromatographic system to distinguish impurities, while others specify a different method. Confirm this in the product instructions and the laboratory validation before ordering QC consumables.
The familiar acetone/saline separation pattern applies only to certain preparations and materials. It is not a universal recipe for labelled complexes, colloids or particles. Use the manufacturer-defined migration assignments and calculations for the exact radiopharmaceutical.
Store and condition chromatography media and solvents according to their instructions. Humidity can affect performance, but oven drying is not suitable for every strip material. Include controls, expiry, storage conditions and method verification in the QC records.
Choose a detector and geometry with validated efficiency, linearity, background and counting uncertainty for the QC method. A gamma counter, suitable chromatographic scanner or other validated instrument may be used. A dose calibrator is not made suitable for low-activity strip or wipe assays simply by using it consistently.
Reporting staff should be able to recognise a labelling failure from the pictures, because the images are the last line of defence when the quality control was skipped.
Unexpected thyroid or gastric activity, liver/spleen uptake or focal pulmonary activity can prompt a radiopharmaceutical review, but these findings are not unique to one preparation error. The responsible clinical team should assess patient factors, product identity, preparation and QC records, injection and imaging before concluding the cause.
Retain and investigate relevant materials and records under the approved quality and radiation-protection procedure. An absence of recorded failures alone does not prove either excellent preparation or a failure to test; assess the documented QC process and its performance.
Quality control that happens when somebody remembers is quality control that happens after the complaint. Turning it into a routine takes five decisions, all of them cheap.
Assign trained staff and cover, product-specific worksheets, clear release authority and a procedure for out-of-specification results. Quarantine non-conforming material and investigate under the approved programme rather than apply a universal two-kit retry rule. Budget compatible media, detectors and bench equipment, including appropriate shielding for the actual radionuclides.
The records join the rest of the department's quality assurance file, and an inspector reads them together with the camera results. How the two fit into one programme is set out in building a gamma camera quality assurance programme, and the layout that makes the bench work is in designing and equipping a radiopharmacy hot lab.
Share your application, equipment requirements and procurement timeline. Our engineers can help clarify the configuration and scope for your enquiry.